Conditions: Obesity Interventions: Drug: BI 456906; Drug: Placebo Sponsors: Boehringer Ingelheim Recruiting Author:
Category: Clinical Trials
Information and news about current clinical trials
A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)
Conditions: NonSegmental Vitiligo Interventions: Drug: Povorcitinib; Drug: Placebo Sponsors: Incyte Corporation Recruiting Author:
INcreased Sun Exposure Without Pain In Research Subjects With EPP
Conditions: Erythropoietic Protoporphyria (EPP); X-Linked Protoporphyria (XLP) Interventions: Drug: Dersimelagon; Drug: Placebo Sponsors: Mitsubishi Tanabe Pharma America Inc. Recruiting Author:
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers
Conditions: Respiratory Syncytial Virus Interventions: Biological: mRNA-1345; Biological: Placebo Sponsors: ModernaTX, Inc. Recruiting Author:
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.
Conditions: Influenza; COVID-19 Interventions: Biological: Influenza and COVID-19 Combination A; Biological: Licensed influenza vaccine; Biological: COVID-19 Vaccine; Biological: Influenza and COVID-19 Combination B; Biological: Placebo Sponsors: BioNTech SE; Pfizer Not yet recruiting Author:
Comparison of the Effectiveness of Acupuncture Treatment With Conventional Rehabilitation Methods in Multiple Sclerosis Patients
Conditions: Multiple Sclerosis Interventions: Other: Acupuncture; Other: Conventional Rehabilitation Sponsors: Ankara City Hospital Bilkent Recruiting Clinical Trials online
The Impact of Body Weight on Clinical and Immunological Outcomes in Relapse-Remitting Multiple Sclerosis Patients
Conditions: Multiple Sclerosis Interventions: Other: Blood sample collection Sponsors: German University in Cairo Active, not recruiting Clinical Trials online
A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis
Conditions: Multiple Sclerosis (MS) Interventions: Drug: elezanumab; Drug: placebo Sponsors: AbbVie Completed Clinical Trials online
A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis
Conditions: Multiple Sclerosis (MS) Interventions: Drug: elezanumab; Drug: placebo Sponsors: AbbVie Completed Clinical Trials online
Effectiveness of Cladribine Tablets in Participants With Highly-active Relapsing Multiple Sclerosis (CAMELOT-MS)
Conditions: Relapsing-Remitting Multiple Sclerosis Sponsors: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany; Merck Serono Limited, an affiliate of Merck KGaA, Darmstadt, Germany Completed Clinical Trials online
Study Evaluating Kesimpta® Treatment Effects in Patients With Relapsing Multiple Sclerosis Transitioning From Other Therapies
Conditions: Multiple Sclerosis Interventions: Other: Ofatumumab Sponsors: Novartis Pharmaceuticals Active, not recruiting Clinical Trials online
Neurostatus-SMARTCARE in Comparison to Standard Neurostatus-EDSS®
Conditions: Multiple Sclerosis (MS) Interventions: Other: Neurostatus-SMARTCARE; Other: Standard Neurostatus-EDSS Sponsors: University Hospital, Basel, Switzerland; Novartis Pharma AG, Basel, Switzerland Active, not recruiting Clinical Trials online